{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:53:52Z","timestamp":1784631232573,"version":"3.55.0"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"10","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Geburtshilfe Frauenheilkd"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cervical cancer screening, which was introduced into the programme of medical care covered by statutory health insurance in Germany in 1971 and has since been constantly updated through\n            quality assurance measures, was fundamentally revised and developed in 2008 through the Cervical Cytology Quality Assurance Agreement pursuant to Section 135(2) of the German Social Code\n            Book V [SGB V]. Since 2015 it has been mandatory for cytology facilities to record annual statistics based on the Munich Nomenclature III. The aim of this article is to present the results\n            of the annual statistics for 2019, which was the last year before the introduction of the cervical cancer screening programme in accordance with the Federal Joint Committee\u2019s guideline on\n            organised cancer screening programmes 1.<\/jats:p><jats:p>The annual statistics of the laboratories, including histology analyses performed up until 30 June the following year, are reported to the Regional Associations of Statutory Health\n            Insurance Physicians. The laboratories receive benchmark reports from their Regional Associations of Statutory Health Insurance Physicians, and these statistics are transmitted anonymously\n            to the National Association of Statutory Health Insurance Physicians (KBV).<\/jats:p><jats:p>In 2019, 17609082 smears from 15608413 women were examined in Germany. Of these smears, 97.49% were normal and 2.51% showed atypical or suspicious changes, consisting mostly of minor\n            squamous epithelial changes in groups\u00a0II-p (0.81%) and IIID1 (0.735%).<\/jats:p><jats:p>Histology specimens are available for \u201cDysplasia findings with higher probability of regression\u201d in group\u00a0IIID1 (4.89% of initial IIID1 cytology findings), group\u00a0IIID2 (18.60%), \u201cunclear\n            or doubtful findings\u201d in group\u00a0III-p to x (20.7%), and \u201cimmediate precursors to cervical carcinoma\u201d in group\u00a0IV (83.1%) and group\u00a0V (77.19%).<\/jats:p><jats:p>In the cytology findings for group\u00a0IVa-p, which corresponds to CIN\u00a03 target lesions, the cytology correlated with the histology finding in 80.48% of cases.<\/jats:p><jats:p>Lesions found in 2019: 23463 CIN\u00a03 lesions, 668 adenocarcinomas in situ, 3891 malignant tumours, including 2342 cervical carcinomas of which 1743 were squamous cell carcinomas and 599\n            were cervical adenocarcinomas (25.57%); 1549 endometrial carcinomas and other malignancies.<\/jats:p><jats:p>The data demonstrate the good practicability of cervical cancer screening in 2019. Higher grade lesions were reliably clarified histologically.<\/jats:p>","DOI":"10.1055\/a-2134-6740","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:57:01Z","timestamp":1695423421000},"page":"1235-1249","source":"Crossref","is-referenced-by-count":7,"title":["Evaluations of the 2019 Annual Statistics Under the Cervical Cytology Quality Assurance Agreement"],"prefix":"10.1055","volume":"83","author":[{"given":"Ulrich","family":"Schenck","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Allgemeine Pathologie und Pathologische Anatomie, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Hantschke-Zerbich","sequence":"additional","affiliation":[{"name":"Dezernat Versorgungsqualit\u00e4t, Kassen\u00e4rztliche Bundesvereinigung Kd\u00f6R, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Woellner","sequence":"additional","affiliation":[{"name":"Dezernat Versorgungsqualit\u00e4t, Kassen\u00e4rztliche Bundesvereinigung Kd\u00f6R, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Michel","sequence":"additional","affiliation":[{"name":"Dezernat Versorgungsqualit\u00e4t, Kassen\u00e4rztliche Bundesvereinigung Kd\u00f6R, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"ref1","first-page":"B3","volume-title":"Richtlinie f\u00fcr organisierte Krebsfr\u00fcherkennungsprogramme. OKFE-RL vom 26.01.2023. 18.10.2018","author":"Gemeinsamer Bundesausschuss"},{"key":"ref2","first-page":"A2446","article-title":"Bekanntmachungen: Vereinbarung von Qualit\u00e4tssicherungsma\u00dfnahmen nach \u00a7 135 Abs. 2 SGB V zur zytologischen Untersuchung von Abstrichen der Cervix uteri (Qualit\u00e4tssicherungsvereinbarung\n          Zervix-Zytologie)","volume":"104","author":"Kassen\u00e4rztliche Bundesvereinigung","year":"2007","journal-title":"Dtsch Arztebl Ausg A"},{"key":"ref3","first-page":"1042","article-title":"M\u00fcnchner Nomenklatur III","volume":"54","author":"H Griesser","year":"2013","journal-title":"Frauenarzt"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System. Terminology for reporting results of cervical cytology","volume":"287","author":"D Solomon","year":"2002","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00129-019-4417-7","article-title":"An der Schwelle zum organisierten Zervixkarzinomscreening. Befunde der M\u00fcnchner Nomenklatur III und zytologischhistologische Korrelation","volume":"52","author":"K Marquardt","year":"2019","journal-title":"Gyn\u00e4kologie"},{"key":"ref8","series-title":"Wissenschaftliche Reihe des Zentralinstituts f\u00fcr die kassen\u00e4rztliche Versorgung in der Bundesrepublik Deutschland","volume-title":"Inanspruchnahme der Fr\u00fcherkennung auf Zervixkarzinom in den Jahren 2002\u20132004. Eine Untersuchung auf der Basis von Sekund\u00e4rdaten im Auftrag des Gemeinsamen Bundesausschusses gem\u00e4\u00df \u00a7 91 SGB\n          V","author":"H Kerek-Bodden","year":"2010"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000331529","article-title":"Terminology","volume":"42","author":"U Schenck","year":"1998","journal-title":"Acta Cytol"},{"key":"ref10","first-page":"726","article-title":"Die zytologische Diagnose einer Dysplasie leichten und mittleren Grades","volume":"38","author":"H Sander","year":"1978","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref11","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","author":"ML Carcangiu","year":"2014","edition":"4"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver Reproducibility of Cervical Cytologic and Histologic Interpretations \u2013 Realistic Estimates from the ASCUS LSIL Triage Study","volume":"285","author":"MH Stoler","year":"2001","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/ijc.25470","article-title":"The accuracy of colposcopic biopsy. Analyses from the placebo arm of the Gardasil clinical trials","volume":"128","author":"MH Stoler","year":"2011","journal-title":"Int J Cancer"},{"key":"ref14","first-page":"522","article-title":"Konisation oder kolposkopisch gesteuerte Portiobiopsie?","volume":"49","author":"B Mangold","year":"2009","journal-title":"Frauenarzt"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"321.e1","DOI":"10.1016\/j.ajog.2010.05.033","article-title":"Diagnostic accuracy of guided cervical biopsies. A prospective multicenter study comparing the histopathology of simultaneous biopsy and cone specimen","volume":"203","author":"C Zuchna","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"ref16","first-page":"446","article-title":"High pathologic misdiagnosis of cervical adenocarcinoma in situ","volume":"34","author":"SM Jordan","year":"2013","journal-title":"Eur J Gynaecol Oncol"},{"key":"ref17","first-page":"8","article-title":"The validation of cervical cytology. Sensitivity, specificity and predictive values","volume":"35","author":"HJ Soost","year":"1991","journal-title":"Acta Cytol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/a-0828-7722","article-title":"Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015\/027OL, December 2017) \u2013 Part 2 on Triage, Treatment and Follow-up","volume":"79","author":"P Hillemanns","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/a-0818-5440","article-title":"Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015\/027OL, December 2017) \u2013 Part 1 with Introduction, Screening and the Pathology of\n          Cervical Dysplasia","volume":"79","author":"P Hillemanns","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/a-1671-2446","article-title":"Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No.\u2009032\/033OL, May 2021) \u2013 Part 2 with Recommendations on Psycho-oncology,\n          Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities","volume":"82","author":"T Fehm","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/a-1671-2158","article-title":"Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No.\u2009032\/033OL, May 2021) \u2013 Part 1 with Recommendations on Epidemiology,\n          Screening, Diagnostics and Therapy","volume":"82","author":"MW Beckmann","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"}],"container-title":["Geburtshilfe und Frauenheilkunde"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2134-6740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:29:18Z","timestamp":1696580958000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2134-6740"}},"subtitle":["2019 Annual Statistics for Cervical Cytology from 15608413 Women"],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,2]]},"published-print":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2134-6740","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0016-5751","1438-8804"],"issn-type":[{"value":"0016-5751","type":"print"},{"value":"1438-8804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]}}}